Can an immune booster stop serious infections in blood cancer patients?
Prevention
Recruiting now
This phase 3 trial is testing whether adding Gamunex-C (an immune globulin) to standard care can prevent serious infections in people with chronic lymphocytic leukemia, multiple myeloma, or non-Hodgkin lymphoma. About 49 participants will receive Gamunex-C through an IV every 4 w…
Phase: PHASE3 • Sponsor: Grifols Biologicals, LLC • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC